RT Journal
A1 Island ER, Pomposelli J, Pomfret EA, Gordon FD, Lewis W, Jenkins RL
T1 TWenty-year experience with liver transplantation for hepatocellular carcinoma
JF Archives of Surgery
JO Archives of Surgery
YR 2005
FD April 1
VO 140
IS 4
SP 353
OP 358
DO 10.1001/archsurg.140.4.353
UL http://dx.doi.org/10.1001/archsurg.140.4.353
AB Hypothesis 
    Liver transplantation (LT) has become the optimal treatment for stages I and II hepatocellular carcinoma (HCC). Based on our 20-year experience, changes in staging, techniques, and patient selection have improved survival over the past 20 years. Herein, we determine if pre-LT treatment for HCC alters the long-term outcomes in patients with HCC.Design 
    Outcomes study.Setting 
    Tertiary referral center.Patients 
    We retrospectively reviewed prospectively collected data in a cohort of 92 patients who underwent LT for HCC between 1983 and 2003.Main Outcome Measures 
    Patient demographics, tumor stage in the explant liver, patient survival, and tumor recurrence data were analyzed.Results 
    The average follow-up was 1052 (range, 0-6491) days. The average tumor size was 3.6 cm; 40% of tumors were multifocal and 60% unifocal. Of the 92 patients, 26% were classified as stage I; 42%, stage II; 24%, stage III; and 8%, stage IV. The overall 5-year survival rate was 50%, the 10-year survival rate was 32%, and the 15-year survival rate was 27%. Improvements in staging in the last 5 years reduced the number of patients with stages III and IV HCC from 39% to 19% and increased the 5-year survival rate to 69%. Tumor recurrence was relatively rare (13%); however, recurrence resulted in a poor prognosis (75% mortality rate; P = .02). The average time to recurrence was 458 (range, 179-1195) days.Conclusions 
    Liver transplantation for HCC results in excellent long-term survival for patients with stages I and II HCC, with relatively few patients dying from tumor recurrence. Improvements in preoperative staging have resulted in increased 5-year survival rates. Further refinements in pre-LT staging may increase the effectiveness of LT for HCC.